Table 4 Fine and Gray model evaluating the association between NT-ProBNP levels and cardiovascular mortality according to baseline HbA1c levels
From: NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
Population | NT-ProBNP (pg/ml) | Cardiovascular mortality | ||
|---|---|---|---|---|
HR | 95% CI | p-value | ||
Whole population | Per 1 SD | 1.07 | 1.02–1.13 | 0.009 |
 < 100 | 1.00 | Ref |  | |
100–299 | 1.57 | 1.17–2.10 | 0.003 | |
 ≥ 300 | 2.08 | 1.47–2.93 |  < 0.001 | |
HbA1c < 5.7% | Per 1 SD | 1.17 | 1.07–1.28 | 0.001 |
 < 100 | 1.00 | Ref |  | |
100–299 | 1.35 | 0.87–2.10 | 0.186 | |
 ≥ 300 | 1.79 | 1.05–3.05 | 0.032 | |
HbA1c 5.7–6.4% | Per 1 SD | 1.07 | 0.85–1.35 | 0.577 |
 < 100 | 1.00 | Ref |  | |
100–299 | 2.15 | 1.20–3.85 | 0.010 | |
 ≥ 300 | 3.04 | 1.47–6.28 | 0.003 | |
Diabetes | Per 1 SD | 1.03 | 0.96–1.10 | 0.406 |
 < 100 | 1.00 | Ref |  | |
100–299 | 1.64 | 0.98–2.75 | 0.061 | |
 ≥ 300 | 1.81 | 0.99–3.34 | 0.055 | |